Roberto Rios Valle
Family · San Antonio, TXNPI 1710528567
Payments from drug & device makers
Across 87 payments — averaging $19.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$406
- AbbVie$232
- Novo Nordisk$139
- Nestle Healthcare Nutrition Inc.$125
- Bayer$100
- AstraZeneca$95
- plus $631 from 18 others
What the payments were for
- Food & beverage$1,728100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 22 | $406 |
| AbbVie(2 entities) | 13 | $232 |
| Novo Nordisk | 6 | $139 |
| Nestle Healthcare Nutrition Inc. | 1 | $125 |
| Bayer | 5 | $100 |
| AstraZeneca | 6 | $95 |
| Teva Pharmaceuticals USA, Inc. | 4 | $82 |
| Otsuka America Pharmaceutical, Inc. | 4 | $61 |
| Atland Pharmaceuticals, LLC | 1 | $57 |
| Sunovion Pharmaceuticals Inc. | 5 | $50 |
| Axsome Therapeutics, Inc. | 3 | $49 |
| Lundbeck LLC | 3 | $42 |
| Abiomed | 1 | $35 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $33 |
| GSK | 2 | $32 |
| Alk-abello, Inc | 1 | $30 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $27 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $22 |
| Exact Sciences | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Globus Medical | 1 | $20 |
| Boehringer Ingelheim | 1 | $19 |
| Amgen | 1 | $15 |
| Cumberland Pharmaceuticals, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ZENPEP$125
How this compares
$1,728 in reported general payments places this provider in the 75th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 41 | $60,404 |
| FarxigaDapagliflozin Propanediol | 46 | $59,910 |
| JardianceEmpagliflozin | 27 | $44,173 |
| MounjaroTirzepatide | 29 | $34,941 |
| OzempicSemaglutide | 28 | $30,406 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 27 | $28,842 |
| VraylarCariprazine Hcl | 15 | $23,689 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 18 | $14,080 |
| LinzessLinaclotide | 13 | $13,806 |
| MyrbetriqMirabegron | 15 | $11,895 |
| SteglatroErtugliflozin Pidolate | 13 | $4,939 |
| Clozapine | 12 | $1,973 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 86 | $1,792 |
| Rosuvastatin Calcium | 91 | $1,689 |
| Quetiapine Fumarate | 38 | $1,606 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro, Olanzapine | $406 | $96,02486 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $95 | $73,99164 claims |
| Boehringer IngelheimJardiance | $19 | $44,17327 claims |
| AbbVieVraylar, Linzess | $232 | $37,49628 claims |
| Novo NordiskOzempic | $139 | $30,40628 claims |
| GSKTrelegy Ellipta | $32 | $28,84227 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 15,456 family providers in Texas.
Other family in San Antonio
- Anna CastroSan Antonio$184K
- Natalia FariasSan Antonio$124K
- Ayoade AvworoSan Antonio$111K
- Tina CoppleSan Antonio$97K
- Kim HinojosaSan Antonio$63K
- Kimberly GibergaSan Antonio$36K
- Lashonda CraneHouston$3.4M
- David WeirDallas$959K
- Luba YammineHouston$479K
- Robin BeachHouston$428K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.